BioAge, positive debut on Nasdaq
Ziarul Bursa,
BioAge Labs Inc. , an American clinical-stage biotechnology company that develops therapies for obesity and metabolic diseases, raised approximately $200 million through its initial public offering IPO) held last week on the US market, fiercebiotech. com reports. continuă pe Ziarul Bursa